首页> 外文期刊>The Journal of Thoracic and Cardiovascular Surgery >Reoperations on the pulmonary autograft and pulmonary homograft after the Ross procedure: An update on the German Dutch Ross Registry
【24h】

Reoperations on the pulmonary autograft and pulmonary homograft after the Ross procedure: An update on the German Dutch Ross Registry

机译:Ross手术后肺自体移植和肺同种移植的再手术:德国荷兰Ross注册表的更新

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives: Reinterventions after the Ross procedure are a concern for patients and treating physicians. The scope of the present report was to provide an update on the reinterventions observed in the large patient population of the German-Dutch Ross Registry.Patients and Methods: From 1988 to 2011,2023 patients (age, 39.05 +- 16.5 years; male patients, 1502; adults, 1642) underwent a Ross procedure in 13 centers. The mean follow-up was 7.1 +- 4.6 years (range, 0-22 years; 13,168 patient-years).Results: In the adult population, 120 autograft reinterventions in 113 patients (1.03%/patient-year) and 76 homograft reinterventions in 67 patients (0.65%/patient-year) and, in the pediatric population, 14 autograft reinterventions in 13 patients (0.91%/patient-year) and 42 homograft reinterventions in 31 patients (2.72%/pa-tient-year) were observed. Of the autograft and homograft reinterventions, 17.9% and 21.2% were performed because of endocarditis, respectively. The subcoronary technique in the adult population resulted in significantly superior autograft durability (freedom from autograft reintervention: 97% at 10 years and 91% at 12 years; P < .001). The root replacement technique without root reinforcement (hazard ratio, 2.4; 95% confidence interval, 1.4-4.1) and the presence of pure aortic insufficiency preoperatively (hazard ratio, 2.3; 95% confidence interval, 1.5-3.5) were statistically significant predictors for a shorter time to reoperation. The center volume had a significant influence on the long-term results. The freedom from homograft reoperation for the adults and pediatric population was 97% and 87% at 5 years and 93% and 79% at 12 years, respectively (P < .001), with younger recipient and donor age being significant predictors of a shorter time to homograft reoperation.Conclusions: The autograft principle remains a valid option for young patients requiring aortic valve replacement. The risk of reoperation depends largely on the surgical technique used and the preoperative hemodynam-ics. Center experience and expertise also influence the long-term results. Adequate endocarditis prophylaxis might further reduce the need for reoperation.
机译:目标:Ross手术后的再次干预是患者和主治医生的关注点。本报告的目的是提供在德荷罗斯登记处大量患者中观察到的再干预的最新信息。患者与方法:1988年至2011年,2023例患者(年龄,39.05±16.5岁;男性患者) (1502年;成人,1642年)在13个中心接受了罗斯手术。平均随访时间为7.1±4.6年(范围0-22岁; 13,168病人年)。结果:在成年人群中,在113例患者中进行了120例自体植骨再干预(1.03%/患者年)和进行了76例同种异体再植在67例患者中(0.65%/患者年),在儿科患者中,有13例患者(14%)(0.91%/患者年)进行了14例自体移植再介入,31例患者(2.72%/人-年)进行了42例同种异体移植。观测到的。自体移植和同种移植的再介入中,由于心内膜炎分别进行了17.9%和21.2%。在成人人群中,亚冠状动脉技术可显着提高自体移植物的耐久性(不受自体移植物再干预的影响:10年时为97%,12年时为91%; P <.001)。术前无根的根置换技术(危险比,2.4; 95%置信区间,1.4-4.1)和术前存在纯主动脉瓣关闭不全(危险比,2.3; 95%置信区间,1.5-3.5)是统计学上重要的预测指标重新手术的时间更短。中心体积对长期结果有重大影响。成人和小儿接受同种异体再手术的自由度在5岁时分别为97%和87%,在12岁时分别为93%和79%(P <.001),较年轻的接受者和供体年龄是较短的重要预测因素结论:自体移植原则仍然是需要更换主动脉瓣的年轻患者的有效选择。再次手术的风险在很大程度上取决于所使用的手术技术和术前的血液动力学。中心的经验和专业知识也会影响长期结果。充分预防心内膜炎可能会进一步减少再次手术的需要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号